DMP — Dermapharm Holding SE Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for Dermapharm Holding SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	123	173	162	160	122
Net Total Accounts Receivable
Net Total Receivables	57.8	84.2	103	97.9	112
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	400	519	534	630	593
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	200	222	226	331	315
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,224	1,407	1,413	2,161	2,080
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	133	156	218	394	327
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	902	910	881	1,621	1,476
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	322	497	532	539	604
Total Liabilities & Shareholders' Equity	1,224	1,407	1,413	2,161	2,080
Total Common Shares Outstanding